Pay in 4 interest-free payments of $5.00 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
Check your eligibility Switch to Tirzepatide If semaglutide hasn't worked, tirzepatide's dual mechanism may be more effective
The ACHIEVE-1 phase 3 trial (NCT05971940) demonstrates promising results regarding the use of orforglipron for the treatment of type 2 diabetes
Diabetes and weight-loss trials have shown that the GLP-1 drugs target hormones in the gut and the brain that control appetite and feelings of fullness, cutting down on what's described as food noise, or intrusive thoughts of food
Reduced fat mass and increased lean mass in response to 1 year of melatonin treatment in postmenopausal women: a randomized placebo-controlled trial
In 2021, it was approved for chronic weight management as Wegovy
Macquarie University, Sydney, Australia (2022)
